Welcome : Guest

Gilead Sciences, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Gilead Sciences, Inc., which is principally a Biopharmaceutical Company. Illustrated with 84 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-00246
Price: $3500
Company Type: Public
Pages: 94
Date: November 2016
Market Data Tables: 84

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Gilead Sciences, Inc.’s Sales by Product Category Worldwide (2015) in Percentage for Antiviral Products (Harvoni, Sovaldi, Truvada, Atripla, Stribild, Complera/Eviplera and Viread), Other Products (Letairis, Ranexa, AmBisome, and Others), and Others......6
Table 2: Gilead Sciences, Inc.’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for USA, Europe, and Other Countries......7
Biopharmaceuticals......12
Table 3: Biopharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Norditropin, NovoSeven, Turoctocog Alpha, and Others......12
Pharmaceuticals......13
Table 4: Pharma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Injectables, Oral Solids, Tropicals and Others......13
Table 5: Pharmaceutical Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for China, Japan, USA and Others......14
Table 6: Pharmaceuticals Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia, Africa, and Australasia, European Union, Japan, Latin America, and North America......15
Table 7: Pharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Generic, Originator Brand, and Others......16
Table 8: Pharmaceuticals Sales by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for Active Pharmaceutical Ingredients, Contrast Products, Radiopharmaceuticals, and Specialty Pharmaceuticals......17
Table 9: Pharmaceuticals Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics and Chemical Synthetic and Others......18
Table 10: New Pharmaceutical Licensed Drugs Market by Indication Worldwide (2015) - Percentage Share Breakdown by Value Sales for AIDS, Diabetes, Diabetes (DPP4), Hepatitis B, Hypertension, and Others......19
Table 11: New Pharmaceutical Licensed Drugs Market by Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Humulin, Trajenta, Truvada, Twynsta, Viread, and Others......20
Table 12: Emerging Market Pharma Sales by Country Worldwide (2015) - Percentage Share Breakdown by Value Sales for Africa & Middle East, Brazil, China, India, Russia, and Others......21
Table 13: Research & Development Spending in Pharmaceuticals by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for Approval, Discovery, Pre-Clinical, Phase I, Phase II, Phase III, Phase IV, and Others......22
Table 14: Pharmaceutical Consumption by Category in Australia (2015) - Percentage Share Breakdown for Aged over 65 Years, and Aged under 65 Years......23
Table 15: Pharmaceutical Market by Region in Brazil (2015) - Percentage Share Breakdown by Value Sales for Mid-West, North, Northeast, São Paulo, South, and Others......24
Table 16: Pharmaceutical Sales by Category in Brazil (2015) - Percentage Share Breakdown by Value for Generics, Over the Counter (OTC) Drugs, and Prescription......25
Table 17: Pharmaceutical Market by Category in Canada (2015) - Percentage Share Breakdown by Value for Hospital and Retail......26
Table 18: Pharmaceutical Distribution Market by Region in China (2015) - Percentage Share Breakdown by Value for Eastern China, North East China, Northern China, Northwestern China, Southern China, and Southwestern China......27
Table 19: Pharmaceuticals Market by Therapeutic Area in China (2015) - Percentage Share Breakdown by Value Sales for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular Diseases, Musculo-Skeletal System, Nervous System, Oncology, Respiratory System, Systemic Anti-Infective, and Others......28
Table 20: Pharmaceutical Market by Country in Europe (2015) - Percentage Share Breakdown by Value Sales for France, Germany, Greece, Italy, Spain, UK, and Others......29
Table 21: Pharmaceutical Drugs Market by Category in Germany (2015) - Percentage Share Breakdown by Value Sales for Biopharmaceuticals, Pharma Drugs for Human Use, and Others......30
Table 22: Pharma Market by Category in Indonesia (2015) - Percentage Share Breakdown by Value for Branded Generics and Licensed, Over the Counter and Unbranded Generics......31
Table 23: Pharmaceutical Market by Region in Latin America (2015) - Percentage Share Breakdown by Value for Argentina, Brazil, Mexico, Venezuela and Others......32
Table 24: Retail Pharmaceutical Market by Type in Mexico (2015) - Percentage Share Breakdown by Value for Private Market and Public Market......33
Table 25: Spending on Pharmaceutical by Category in Nigeria (2015) - Percentage Share Breakdown by Value for Generic Drug Sales, Over-The-Counter Medicine Sales and Patented Drug Sales......34
Table 26: Private Pharmaceuticals Market by Segment in South Africa (2015) - Percentage Share Breakdown by Value for Branded and Ethical, Generic, Over the Counter and Others......35
Table 27: Pharmaceutical Drugs Manufacturers by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Biological Products, Medicinal and Botanical Products, Oncological Products, and Others......36
Table 28: Speciality Pharmaceuticals Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Anti-Coagulant, Growth Hormone, Hepatitis C, HIV/AIDS (incl oral solids), IVIG/Hemophilia, Macular Degeneration, Multiple Sclerosis, Oncology (incl. oral solids), Pulmonary Arterial Hypertension, Renal, Rheumatoid arthritis/Chrohn's, Transplant, and Others......37
Table 29: Pharmaceutical Market by Category in Vietnam (2015) - Percentage Share Breakdown by Value for Generic Drugs, Patented Drugs and Others......38
Hepatitis B......39
Table 30: No. of Hepatitis B Patients by Region in Europe (2015) - Percentage Market Share Breakdown by Volume for Eastern Europe, and Western Europe......39
Table 31: No. of Hepatitis B Patients by Country in Eastern Europe (2015) - Percentage Market Share Breakdown by Volume for Hungary, Poland, and Romania......40
Table 32: No. of Hepatitis B Patients by Country in West Europe (2015) - Percentage Market Share Breakdown by Volume for France, Germany, Italy, Netherlands, Spain, United Kingdom, and Others......41
Hepatitis C......42
Table 33: Hepatitis C Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Immuno Modulator, Polymerase Inhibitor, Protease Inhibitors, and Others* (Includes Ribavirin)......42
Table 34: Hepatitis C Market by Genotype Worldwide (2015) - Percentage Share Breakdown by Value for Genotype 1, Genotype 2 and Others......43
Table 35: Hepatitis C Virus Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Immuno-Modulator, Polymerase Inhibitor, Protease Inhibitors, Ribavirin, and Others......44
Table 36: Hepatitis C Virus Market by Patient Conditions in Europe (2015) - Percentage Share Breakdown by Value for Diagnosed, Prevalence, Under Care and Others......45
Table 37: No. of Hepatitis C Virus (HCV) Patients by Category in European Union (EU) (2015) - Percentage Market Share Breakdown for GT1, and Non-GT1......46
Table 38: Hepatitis C Virus Market by Patient Conditions in the US (2015) - Percentage Share Breakdown by Value for Diagnosed, Prevalence, Under Care and Others......47
Table 39: Health Insurance for Hepatitis C Virus (HCV) by Type in the US (2015) - Percentage Market Share Breakdown by Value for Commercial, Dual (Medicare and Medicaid), Medicaid, Medicare (Non- Dual), Prison, Uninsured, and Veteran Affairs......48
Table 40: No. of Hepatitis C Virus (HCV) Patients by Category in the US (2015) - Percentage Market Share Breakdown for GT1 HCV, GT2/3 HCV, and Others......49
Pulmonary Arterial Hypertension (PAH)......50
Table 41: Pulmonary Arterial Hypertension (PAH) Treatment by Drug Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Adcirca, Letairis/Volibris, Remodulin, Revatio, Tracleer, Tyvaso and Ventavis......50
Table 42: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy Worldwide (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......51
Table 43: Pulmonary Arterial Hypertension (PAH) Treatment with Macitentan Drug by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Japan, US and Rest of World......52
Table 44: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......53
Table 45: Pulmonary Arterial Hypertension (PAH) Treatment by Type Worldwide (2015) - Percentage Breakdown by Value for Inhaled Prostacyclins, Orals (ERAs, PDE5s, Prostacyclins), and Parenteral Prostacyclins......54
Table 46: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in Europe (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......55
Table 47: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in Europe (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......56
Table 48: Pulmonary Arterial Hypertension Treatment Market by Product Segment in Japan (2015) - Percentage Share Breakdown by Value for Adcirca, Dorner, Flolan, Procylin, Revatio, and Tracleer......57
Table 49: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in the US (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......58
Table 50: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in the US (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......59
Respiratory Drugs......60
Table 51: Respiratory Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue, and Rhinitis......60
Table 52: Respiratory Therapeutic Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue and Rhinitis......61
Oncology Genomics......62
Table 53: Oncology Genomics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......62
Table 54: Oncology Genomics (Clinical, Hereditary, and Molecular Monitoring) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......63
Table 55: Oncology Genomics Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......64
Table 56: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Ltd., Lonza Group Ltd., Pfizer, Inc., Sanofi S.A., and Others......65
Table 57: Market Shares of Leading Biopharmaceutical Companies in the US (2015) - Percentage Market Share Breakdown by Value for Actelion Pharmaceuticals Ltd., Alexion Pharmaceuticals, Inc., Celgene Corporation, Gilead Sciences, Inc., Incyte, Corporation, Isis Pharmaceuticals, Inc., Vertex Pharmaceuticals, Inc., and Others......66
Table 58: Market Shares of Leading New Pharmaceutical Licensed Drug Companies by Value Sales Worldwide (2014) - Percentage Breakdown for C.H. Boehringer Sohn AG & Ko. KG, Eli Lilly and Company, Gilead Sciences, and Others......67
Table 59: Market Shares of Leading Pharmaceutical Companies in Australia (2015) - Percentage Share Breakdown by Value for AstraZeneca, Pfizer, Inc. and Others......68
Table 60: Market Shares of Leading Pharmaceutical Distributors in Brazil (2015) - Percentage Share Breakdown by Value for Panpharma Participacoes S.A., Profarma Distribuidora de Produtos Farmaceuticos S.A., Santa Cruz and Other......69
Table 61: Market Shares of Leading Pharmaceutical Companies in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma Tbk., Pfizer Indonesia PT Tbk, Sanbe Farma PT, and Others......70
Table 62: Market Shares of Leading Pharmaceutical Suppliers to Hospitals in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma, Tbk, Sanbe Farma PT, Soho Group, and Others......71
Table 63: Market Shares of Leading Pharmaceutical Drugs Manufacturers in the US (2015) - Percentage Breakdown by Value for Amgen, Eli Lilly and Co., Johnson and Johnson Co, Merck & Co., Inc., Pfizer, Inc., and Others......72
Table 64: Market Shares of Leading Pharmaceutical Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Abbott Laboratories, Amgen Corporation, AstraZeneca Plc, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......73
Preclinical Pharmaceuticals......74
Table 65: Market Shares of Leading Preclinical Pharmaceutical Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Charles River Laboratories International, Inc. (CRL), Covance, Inc. (CVD), Pharmaceutical Product Development Inc. (PPDI), Wuxi Pharmatech (Cayman) Inc. (WX), and Others......74
Prescription Pharmaceuticals......75
Table 66: Market Shares of Leading Prescription Pharmaceutical Companies in Indonesia (2015) - Percentage Breakdown by Volume Sales for Dexa Medica Group, Interbat Pharmaceutical Industry PT, PT Kalbe Farma, Tbk, PT Sanbe Farma, and Others......75
Table 67: Market Shares of Leading RX Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Eurofarma Laboratórios, Hypermarcas S.A.,Pfizer, Inc., Roche AG, Sanofi - Medley Indústria Farmacêutica Ltda and Others......76
Table 68: Market Shares of Leading Prescription Pharmaceutical Companies in the US (2014) - Percentage Market Share Breakdown by Volume Sales for Actavis Plc, Amneal, Inc., Endo Pharma, Inc., Lupin Pharmaceuticals, Inc., Mylan Labs,Inc., Novartis International AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and Others......77
Table 69: Market Shares of Leading Prescription Drug Companies in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries, Ltd., and Others......78
Table 70: Market Shares of Leading Prescription Drug Companies Spending through Media Ads in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......79
RadioPharmaceuticals......80
Table 71: Market Shares of Leading Radiopharmaceutical Drug Providers in the US (2015) - Percentage Breakdown by Value for Amersham Plc, Cardinal Health, Inc., Independents, and Triad Healthcare Inc.......80
HBV/HCV Therapeutics......81
Table 72: Market Shares of Leading HBV/HCV Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., and Others......81
Table 73: Market Shares of Leading Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bristol-Myers Squibb Co (BMY), GlaxoSmithKline Plc (GSK), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Vertex Pharmaceuticals, Inc. (VRTX), and Others......82
Hepatitis B Drugs......83
Table 74: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales in Korea (2014) - Percentage Breakdown for Bemis Company, Inc. (BMS), Bukwang Pharmaceutical Co., Ltd (Levovir), GlaxoSmithKline Plc (Hopsera, Zeffix), Novartis International AG (Sebivo), and Others......83
Table 75: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bemis Company, Inc.(Baraclude), F. Hoffmann-La Roche AG (Pegasys), GlaxoSmithKline Plc (Hepsera, Zeffix), and Novartis International AG (Sebivo)......84
HIV Drugs......85
Table 76: HIV Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)/ Nucleoside Reverse Transcriptase Inhibitor (NRTI) Fixed Dose Combination (FDC), Nucleoside Reverse Transcriptase Inhibitor (NRTI)/Retroviral Integrase/CYP3A, Nucleoside Reverse Transcriptase Inhibitor (NRTIs), Protease Inhibitors, Retroviral Integrase (IN), and Others* (Includes NNRTIs)......85
Table 77: HIV Regimens for New Start Patients by Segment in European Union (2015) - Percentage Market Share Breakdown by Value Sales for Atripla, Compler, Stribild, Truvada and Others......86
Table 78: HIV Regimens for Experienced Patients by Segment in the US (2015) - Percentage Market Share Breakdown by Value Sales for Atripla, Stribild, Truvada and Others......87
Table 79: HIV Regimens for New Start Patients by Segment in the US (2015) - Percentage Market Share Breakdown by Value Sales for Atripla, Compler, Stribild, Truvada and Others......88
Deproteinized Calf Serum Injection......89
Table 80: Market Shares of Leading Deproteinized Calf Serum Injection Manufacturers in China (2015) - Percentage Share Breakdown by Value for Aohong Yaoye, Harbin Sanctity Pharmaceutical Co., Ltd., Heilongjiang Jiangshi Pharmaceutical Co., Ltd. and Others......89
Hematology Analyzers......90
Table 81: Market Shares of Leading Hematology Analyzers Manufacturers by Value Sales in China (2014) - Percentage Breakdown for Mindray Medical International Limited, and Others......90
Hematology Medical Equipment......91
Table 82: Market Shares of Leading Hematology Medical Equipment Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Beckman Coulter, Inc., Mindray Medical International Limited and Sysmex Corporation......91
Table 83: Market Shares of Leading Hematology Medical Equipment Manufacturers Worldwide (2015) - Percentage Breakdown by Volume for Mindray Medical International Limited, Prokan Electronics, Inc., Tecom Science Corporation, The Sysmex Corporation, Urit Medical Electronic Co., and Others......92
Table 84: Gilead Sciences, Inc.’s Sales by Geographic Region Worldwide (2013) in Percentage for United States, Europe, and Other Countries......93